Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1

FDA recall notice · announced October 22, 2025 · Integradose Compounding Services

Class I FDA/FSIS Class I: reasonable probability that use will cause serious adverse health consequences or death.

The product

Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1

Reason for recall

Subpotent Drug: Testing revealed there was no oxytocin in the IV bag.

Notes

Distribution: Nationwide in the USA
Lot/code information: Lot #: 20250620OXY-1, Expiration date 10/18/2025
Quantity: 853/500 mL bags
Status: Ongoing
Products in this recall event:
- Oxytocin 30 Units/500 mL in 0.9% Sodium Chloride for intravenous use, Rx only, IntegraDose Compounding Services LLC, 719 Kasota Ave Se, Minneapolis, MN 55414-2842 NDC 71139-0012-1 (D-0015-2026)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.